Update to NCCN Guidelines on Infection

August 7, 2009
Christin Melton

The National Comprehensive Cancer Network (NCCN) has added information on the H1N1 (swine flu) virus to its clinical practice guidelines on the Prevention and Treatment of Cancer-Related Infections.

The National Comprehensive Cancer Network (NCCN) has added information on the H1N1 (swine flu) virus to its clinical practice guidelines on the Prevention and Treatment of Cancer-Related Infections. In the section on treating lung infiltrates in patients with febrile neutropenia, the guidelines have been revised to note that some tests and antiviral treatments typically used for common strains of influenza and other respiratory viruses "may not be applicable" to the H1N1 strain and other pandemic strains.

The NCCN also added dorpenam (Doribax) to the Anctibacterial Agents Tables and tenofovir disoproxil fumarate (Viread) to the Antiviral Agents Tables. The updated guidelines are available at the NCCN Website, at NCCN.org.